PDGFRB and glioblastoma: In fact, we have shown that a highly potent inhibitor of PDGFR activity, Crenolanib, induced apoptosis in several GBM CSC (p-CSC and c-CSC) which increased in combination with the inhibition of EGFR activity [23].